Cargando…
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
There are no approved therapies for Ebola virus infection. Here, to find potential therapeutic targets, we perform a screen for genes essential for Ebola virus (EBOV) infection. We identify GNPTAB, which encodes the α and β subunits of N-acetylglucosamine-1-phosphate transferase. We show that EBOV i...
Autores principales: | Flint, Mike, Chatterjee, Payel, Lin, David L., McMullan, Laura K., Shrivastava-Ranjan, Punya, Bergeron, Éric, Lo, Michael K., Welch, Stephen R., Nichol, Stuart T., Tai, Andrew W., Spiropoulou, Christina F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336797/ https://www.ncbi.nlm.nih.gov/pubmed/30655525 http://dx.doi.org/10.1038/s41467-018-08135-4 |
Ejemplares similares
-
Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2018) -
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
por: Lo, Michael K., et al.
Publicado: (2020) -
Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2020) -
25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2016) -
Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)
por: Lo, Michael K., et al.
Publicado: (2021)